#1---"If I went on prophylatic therapy for a couple of years, is it possible that my valves will heal without surgery or with +2-3+ mitral regurg and mild aortic insufficiency and mild tricuspid regurg would surgery still be indicated?"
Yes, it is possible that your valves might heal without surgery if you adhere to antibiotic prophylactic therapy. Valvular insufficiency caused by acute rheumatic valve disease resolves in 60-80% of patients who adhere to antibiotic prophylaxis. Since you are having recurrent episodes of pharyngitis and symptoms of rheumatic infection, then it is possible to heal your rheumatic valvular pathology by taking prophylactic antibiotic therapy possibly for your entire lifetime.
#2---"valve repair is much more risky than bypass surgery."
Actually, both surgeries have about the same risk because the heart or the aorta are opened. Heart valve surgery is "open heart" surgery. There are new methods of repairing and replacing valves being tried all the time. Some newer valve surgeries are minimally invasive where a valve is repaired/replaced with instruments through a small keyhole incision.
http://www.clevelandclinic.org/heartcenter/pub/guide/disease/mini_invasivehs.htm
#3---"if very brisk walking and treadmill exercise (approximately 3-4 miles/hour would be too taxing for my heart or is this necessary for keeping the heart muscle strong?"
Moderate exercise is therapeutic. Exercise prevents pooling of blood. Stagnant "pooled" blood contributes to the formation of thrombi (clots). Moderate exercise maintains the flow of fresh oxygenated blood through your valves; therefore, exercise is an important prophylactic measure to prevent side effects of thrombus formation due to mitral valve regurgitation. Once blood stagnates from bedrest and lack of exercise, there is a higher risk for thrombus formation. You should maintain a "healthy balance" of sufficient rest as well as reasonable exercise so that your heart muscle isn't overly strained by having to pump excessively while you are having symptoms e.g. shortness of breath, swollen lower extremities, nausea, or fatigue. Moderation is the key.
#4---"If the stent has become occluded, the renal indices would probably not be within normal limits, yes/No?"
Yes, it's true that if the stent becomes occluded the renal indices would not be within normal limits. Re-stenosis results in symptom reocurrence e.g. hypertension, and may progress to occlusion and kidney loss; therefore, early stent occlusion-detection using ultrasound is very important to allow effective intervention. Atherosclerotic renal artery stenosis is associated with increased blood pressure and renal insufficiency. The stenosis is frequently located in the ostium of the renal artery. Stent placement is the treatment of choice.
Stenosis in a stent is often caused by myointimal hyperplasia which is usually treated with percutaneous transluminal angioplasty (PTA) and/or repeat stent placement.
#5---"Inasmuch as the lisinopril/diazide does bring the pressure down, can I assume there is no renal disease causing this problem? Could there still be an underlying kidney disease being masked by the medication?"
Systemic hypertension in patients with chronic mitral regurgitation should be aggressively treated with anti-hypertensive agents. Blood pressure goals should be no greater than 139 mm Hg systolic and 89 mm Hg diastolic (guidelines of the sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure).
In hypertensive patients with unilateral or bilateral renal artery stenosis, increases in blood urea nitrogen and serum creatinine may occur while taking lisinopril. Therapeutic manipulation of the renin-angiotensin-aldosterone system is important in treating hypertension and heart failure. Angiotensin converting enzyme (ACE) inhibitors and Angiotensin II (AII) receptor antagonists are used to decrease arterial pressure, ventricular afterload, blood volume, and ventricular preload, as well as inhibit and reverse cardiac and vascular hypertrophy. As a side effect of lisinopril inhibiting the renin-angiotensin-aldosterone system, changes in renal function occur in some patients. In patients with severe congestive heart failure whose renal function may depend on the activity of the renin-angiotensin-aldosterone system, treatment with angiotensin converting enzyme inhibitors, including lisinopril, may be associated with oliguria (less urination than normal) and/or progressive azotemia (abnormal levels of urea, creatinine, various body waste compounds, and other nitrogen-rich compounds in the blood as a result of insufficient filtering of the blood by the kidneys).
#6---"If I go on as I am now with simply masking symptoms with drugs, what would my average longevity be?"
Your prognosis depends on the condition of your left ventricle. Occasionally mitral regurgitation is asymptomatic for many years, during which time left ventricular structure and function becomes progressively worsened. In symptomatic patients with mitral regurgitation who experience fatigue and symptoms of pulmonary venous hypertension, atrial fibrillation develops. The more that a patient's mitral valve leaks, the more the annulus (ring-like structure on the valve where the leaflets are anchored) dilates which results in left atrial dilation which results in left ventricular dilation which results in left ventricular systolic dysfunction. The mitral valve plays an active role in contraction of the left ventricle. A structurally intact mitral valve contributes about 10% to the total ejection fraction of the heart.
When mitral regurgitation goes untreated for long periods of time then it can worsen and cause cardiomyopathy (CM). This is why your cardiologist should follow-up with you every 6 months so that, if necessary, they can repair or replace your valve before you develop CM.
Concomitant pulmonary hypertension and atrial fibrillation increase the morbidity associated with mitral regurgitation and justify early operative intervention.
Although the natural history of mitral regurgitation (MR) is poorly defined, evidence has been found for excess mortality and morbidity in patients with severe MR who are managed conservatively. With improved mortality and morbidity in the surgical management of this condition, we are becoming increasingly aggressive in offering surgery to patients with severe MR. Surgery may be offered even in the absence of symptoms or left ventricular dysfunction, provided that the valve seems reparable, the patient's MR is severe, and the surgical team is experienced in valve repair. Echocardiography is critically important in determining the feasibility of valve repair and accurately assessing the severity of the patient's MR. It also allows assessment of the effect of MR on the left ventricle and the left atrium. [Cardiology Review 2001 Jul-Aug;9(4):210-6]
#7---"I hope my questions do not seem stupid or unnecessary to you!!"
I hope my answers explain sufficiently well so that you can understand your condition so that you will choose appropriate treatment. Your questions stimulate me to give you objective information, just as I would want if I were in your position. It's a truism that the only stupid question is the one that isn't asked.
Edited by morekare on April 29 2006 at 5:08 AM
Please click the green
"ACCEPT" button. A
"BONUS" and
"POSITIVE FEEDBACK" are appreciated!